dalteparin has been researched along with Lichen Planus in 7 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Lichen Planus: An inflammatory, pruritic disease of the skin and mucous membranes, which can be either generalized or localized. It is characterized by distinctive purplish, flat-topped papules having a predilection for the trunk and flexor surfaces. The lesions may be discrete or coalesce to form plaques. Histologically, there is a saw-tooth pattern of epidermal hyperplasia and vacuolar alteration of the basal layer of the epidermis along with an intense upper dermal inflammatory infiltrate composed predominantly of T-cells. Etiology is unknown.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Husein-ElAhmed, H | 1 |
| Gieler, U | 1 |
| Steinhoff, M | 1 |
| Atzmony, L | 1 |
| Reiter, O | 1 |
| Hodak, E | 2 |
| Gdalevich, M | 1 |
| Mimouni, D | 1 |
| Ferahbas, A | 1 |
| Uksal, U | 1 |
| Kutlugun, C | 1 |
| Kontas, O | 1 |
| Akdeniz, S | 1 |
| Harman, M | 1 |
| Atmaca, S | 1 |
| Yaldiz, M | 1 |
| Yosipovitch, G | 1 |
| David, M | 1 |
| Ingber, A | 1 |
| Chorev, L | 1 |
| Lider, O | 1 |
| Cahalon, L | 1 |
| Cohen, IR | 1 |
| Stefanidou, MP | 1 |
| Ioannidou, DJ | 1 |
| Panayiotides, JG | 1 |
| Tosca, AD | 1 |
| Rai, R | 1 |
| Kaur, I | 1 |
| Kumar, B | 1 |
2 reviews available for dalteparin and Lichen Planus
| Article | Year |
|---|---|
Lichen planus: a comprehensive evidence-based analysis of medical treatment.
Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Antifungal Agents; Calcineur | 2019 |
Treatments for Cutaneous Lichen Planus: A Systematic Review and Meta-Analysis.
Topics: Acitretin; Administration, Cutaneous; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Ca | 2016 |
2 trials available for dalteparin and Lichen Planus
| Article | Year |
|---|---|
The management of lichen planus with low-molecular-weight heparin (enoxaparin).
Topics: Adolescent; Adult; Anticoagulants; Drug Administration Schedule; Enoxaparin; Female; Humans; Lichen | 2005 |
Low molecular weight heparin; a novel alternative therapeutic approach for lichen planus.
Topics: Adult; Aged; Drug Evaluation; Enoxaparin; Female; Follow-Up Studies; Humans; Immunosuppressive Agent | 1999 |
3 other studies available for dalteparin and Lichen Planus
| Article | Year |
|---|---|
Low-molecular-weight heparin (enoxaparin) in the treatment of lichen planus.
Topics: Animals; Clinical Trials as Topic; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Ad | 2003 |
Low-dose low-molecular-weight heparin (enoxaparin) is beneficial in lichen planus: a preliminary report.
Topics: Adult; Aged; Biopsy; Enoxaparin; Female; Follow-Up Studies; Humans; Lichen Planus; Lichen Planus, Or | 1998 |
Low-dose low-molecular-weight heparin in lichen planus.
Topics: Adult; Drug Administration Schedule; Enoxaparin; Female; Fibrinolytic Agents; Humans; Injections, Su | 2002 |